A national epidemic of unintentional prescription opioid overdose deaths: How physicians can help control it

Journal of Clinical Psychiatry

Volumn 72, Issue 5, 2011, Pages 589-592

  Paulozzi, Leonard J ^a   Weisler, Richard H ^b,c   Patkar, Ashwin A ^b  

^a NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NARCOTIC ANALGESIC AGENT; PRESCRIPTION DRUG;

CHRONIC PAIN; DEATH; DRUG MONITORING; DRUG OVERDOSE; EPIDEMIC; EVIDENCE BASED PRACTICE; GENERAL PRACTITIONER; HUMAN; INAPPROPRIATE PRESCRIBING; INTRACTABLE PAIN; MENTAL DISEASE; NARCOTIC DEPENDENCE; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHIATRIST; SUBSTANCE ABUSE; SUICIDE; UNITED STATES;

ANALGESICS, OPIOID; HUMANS; OVERDOSE; PAIN; PRESCRIPTION DRUGS; UNITED STATES;

EID: 79959261000     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.10com06560     Document Type: Note

References (25)

1. Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain. 1986;25(2):171-186. doi:10.1016/0304-3959(86) 9091-6 PubMed (Pubitemid 16121641)
2. Joranson DE, Ryan KM, Gilson AM, et al. Trends in medical use and abuse of opioid analgesics. JAMA. 2000;283(13):1710-1714. doi:10.101/jama.283.13.1710 PubMed (Pubitemid 30196211)
3. Substance Abuse and Mental Health Services Administration. Trends in drug-related emergency department visits, 1994-2002 at a glance. http://dawninfo.samhsa.gov/old-dawn/pubs-94-02/shortreports/files/ DAWN-EDvisits-glance.pdf. Accessed March 24, 2011.
4. Boudreau D, Von Korff M, Rutter CM, et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf. 2009;18(12):1166-1175. doi:10.102/pds.183 PubMed
5. US Department of Justice (USDOJ) DEA. ARCOS: Automation of Reports and Consolidated Orders System. www.deadiversion.usdoj.gov/arcos/index.html. Accessed August 27, 2010.
6. Centers for Disease Control and Prevention. WONDER [online database]. 2010. http://wonder.cdc.gov. Accessed October 12, 2010.
7. Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008;300(22):2613-2620. doi:10.101/jama.208.802 PubMed
8. Toblin RL, Paulozzi LJ, Logan JE, et al. Mental illness and psychotropic drug use among prescription drug overdose deaths: a medical examiner chart review. J Clin Psychiatry. 2010;71(4):491-496. doi:10.408/JCP.09m0567blu PubMed
9. Ohio Department of Health. Epidemic of prescription drug overdose in Ohio. 2010. http://www.healthyohioprogram.org/diseaseprevention/dpoison/ drugdata.aspx. Accessed September 1, 2010.
10. Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. The DAWN Report: Highlights of the 2009 Drug Abuse Warning Network (DAWN) findings on drug-related emergency department visits. http://www.oas.samhsa.gov/2k10/DAWN034/EDHighlights.cfm. Updated December 28, 2010. Accessed March 25, 2011.
11. Drug Enforcement Administration. Oxycodone. http://www.deadiversion. usdoj.gov/drugs-concern/oxycodone/summary.htm. Accessibility verified April 6, 2011.
12. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617-627. doi:10.101/archpsyc.62.6. 617 PubMed (Pubitemid 40973437)
13. Grant BF, Stinson FS, Dawson DA, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61(8):807-816. doi:10.101/archpsyc.61.8.807 PubMed (Pubitemid 39031120)
14. Sullivan MD, Edlund MJ, Steffick D, et al. Regular use of prescribed opioids: association with common psychiatric disorders. Pain. 2005;119(1-3):95-103. doi:10.1016/j.pain.205.09.020 PubMed (Pubitemid 41752969)
15. Braden JB, Sullivan MD, Ray GT, et al. Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. Gen Hosp Psychiatry. 2009;31(6):564-570. doi:10.1016/j.genhospsych.209.07.03 PubMed
16. American Academy of Pain Medicine and American Pain Society. The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and the American Pain Society. Clin J Pain. 1997;13(1):6-8. doi:10.1097/02508-197030-03 PubMed
17. Federation of State Medical Boards of the United States I. Model policy for the use of controlled substances for the treatment of pain. http://www.fsmb.org/pdf/2004-grpol-Controlled-Substances.pdf. Accessed June 21, 2007.
18. Chou R, Fanciullo GJ, Fine PG, et al; American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113-130. doi:10.1016/j.jpain.208.10.08 PubMed
19. Von Korff M, Deyo RA. Potent opioids for chronic musculoskeletal pain: flying blind? Pain. 2004;109(3):207-209. doi:10.1016/j.pain.204.02.019 PubMed
20. Elman I, Zubieta JK, Borsook D. The missing P in psychiatric training: why it is important to teach pain to psychiatrists. Arch Gen Psychiatry. 2011;68(1):12-20. doi:10.101/archgenpsychiatry.2010.174 PubMed
21. Stagnitti MN. Antidepressants prescribed by medical doctors in office based and outpatient settings by specialty for the US civilian noninstitutionalized population, 2002 and 2005. Statistical Brief #206. Rockville, MD: Agency for Healthcare Research and Quality; 2008. http://www.meps.ahrq.gov/mepsweb/data-files/publications/st206/stat206.pdf.
22. Baehren DF, Marco CA, Droz DE, et al. A statewide prescription monitoring program affects emergency department prescribing behaviors. Ann Emerg Med. 2009;doi:10.1016/j.anemergmed.209.12.01. PubMed
23. Starrels JL, Becker WC, Alford DP, et al. Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Ann Intern Med. 2010;152(11):712-720. PubMed
24. Washington State Agency Medical Directors' Group. Interagency guidelines on opioid dosing for chronic non-cancer pain. http://www.agencymeddirectors.wa. gov. Accessed March 5, 2011.
25. Governor's Institute on Alcohol and Substance Abuse [North Carolina]. Safer Opioid Prescribing Summary Sheet. http://www.sa4docs.org/sop-kbr. Accessed March 31, 2011.